UPDATE 1-Merck to take on superbugs with Cubist Pharma buy
December 08, 2014 at 08:00 AM EST
Dec 8 (Reuters) - Merck & Co Inc said it would buy Cubist Pharmaceuticals Inc for $8.4 billion plus assumption of debt, giving the major drugmaker an entry into the market for drugs that target so-called superbugs.
